|
| Information on BuGuCh & Partners |
We, BuGuCh & Partners, are an international acting and innovative company, leading in developing and manufacturing.
We operates major facilities in North America, Europe and the Pacific Rim, as well as facilities in China, Japan and Saudi Arabia operated through joint ventures.
We maintain independently or are partners of some production sites in Europe, Asia and South America. Our global network is a strength.
Our products range from natural gas, oil and basic chemical products through innovative intermediates to specialties, high value-added chemicals, crop protection products and pharmaceuticals.
|
|
BuGuCh & Partners also offers: (4-(((2,4-Diaminopteridin-6-yl)methyl)(methyl)amino)benzoyl)-L-glutamic acid hydrate(1:x) (4,6-Dimethylpyrimidin-5-yl)boronic acid (4,6-Dimethylpyrimidin-2-yl)-hydrazine (4,6-Dichloropyridin-3-yl)methanol (4,6-Dichloro-pyrimidin-5-yl)acetaldehyde (4,6-Dichloro-pyrimidin-5-yl)-acetic acid methyl ester (4,5-Dihydro-4,6-dimethyl-5-methylene-1,2,4-triazin-3-yl)urea (4,5-Dihydro-3,4-dimethyl-5-oxo-1H-pyrazol-1-yl)benzenesulfonic acid (4,5,6,7-Tetrahydro-2-methylbenzothiazole-5-yl)dimethylammonium chloride (4,4-Dimethyl-2,5-dioxoimidazolidine-1,3-diyl)diethylene dilaurate (4,4-Dimethyl-2,5-dioxoimidazolidine-1,3-diyl)diethane-2,1-diyl bis([3-mercaptopropionate] (4,4-Difluorocyclohexane)methylamine hydrochloride (4,4,9,9-Tetrakis(4-hexylphenyl)-4,9-dihydro-S-indaceno[1,2-b:5,6-b']dithi ophene-2,7-diyl)bis(trimethylstannane) (4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)benzene (4,4,5,5,6,6,7,7,8,8,9,9,10,10,11,11,11-heptadecafluoro-2-hydroxyundecyl)trimethylammonium iodide (4,4,5,5,6,6,7,7,8,8,9,9,10,10,11,11,11-heptadecafluoro-2-hydroxyundecyl)bis(2-hydroxyethyl)methylammonium iodide (4,4,4-Trifluorobut-1-yl)benzene (4,4'-Dicinnamoyldisulfide)dimethyl ester (4(S)-Phenyloxazolidin-2-on-3-yl)acetic acid (4'-Methyl-[1,1'-biphenyl]-4-yl)boronic acid (4'-Chloro[1,1'-biphenyl]-4-yl)-boronic acid (3Z,5E,7R,8S,9S,11E,13E,15S,16R)-8-Hydroxy-16-[(1S,2R,3S)-2-hydroxy-1-methyl-3-[(2R,4R,5S,6R)-tetrahydro-2,4-dihydroxy-5 (3Z,13E)-octadeca-3,13-dienyl acetate (3Z)-3-Nonen-1-ol (3Z)-3-Hepten-1-ol acetate (3S-Cis)-7a-Methyl-3-phenyltetrahydropyrrolo[2,1-b]oxazol-5(6H)-one (3S-cis)-2,3-dihydro-7a-methyl-3-phenylpyrrolo-[2,1-b]oxazol-5(7ah)-one (3S-Cis)-(+)-3-Isopropyl-7a-methyltetrahydropyrrolo[2,1-b]oxazol-5(6H)-one (3S-cis)-(+)-3,7a-Diphenyltetrahydropyrrolo-[2,1-b]oxazol-5(6H)-one (3S,6S)-3,6-Octanediol (3S,5S)-3,5-Heptanediol (3S,5S)-3,5-Dimethylmorpholine hydrochloride (3S,5S)-3'-Hydroxycotinine (3S,5S)-2,6-Dimethyl-3,5-heptanediol (3S,4S,5R,6R)-6-(Acetoxymethyl)tetrahydro-2H-pyran-2,3,4,5-tetrayl tetraacetate (3S,4S)-tert-Butyl 3-amino-4-fluoropyrrolidine-1-carboxylate (3S,4S)-4-(Boc-Amino)-3-hydroxy-6-methyl-heptanoic acid (3S,4S)-3-[(R)-1-(tert-Butyldimethylsilyloxy)ethyl]-4-[(R)-1-carboxyethyl]-2-azetidinone (3S,4S)-3-Hexyl-4-[(R)-2-hydroxytridecyl]-2-oxetanone (3S,4S)-3,4-Pyrrolidinediol (3S,4R)-tert-Butyl 4-amino-3-methoxypiperidine-1-carboxylate (3S,4R)-Rel-3,4-difluoropyrrolidine hydrochloride (3S,4R)-4-Phenylpyrrolidin-3-ol hydrochloride (3S,4R)-4-(4-Fluorophenyl)-3-hydroxymethyl-1-methylpiperidine (3S,4R)-3-[(1,3-Benzodioxol-5-yloxy)methyl]-4-(4-fluorophenyl)-piperidine maleate (3S,4R)-3-(3,4-Methylene dioxyphenoxy methyl)-4-(4'-fluorophenyl)-N-methyl piperidine (3S,4R)-3,4-Dihydro-3-hydroxy-2,2-dimethyl-4-(2-oxo-1-pyrrolidinyl)-2H-1-benzopyran-6-carbonitrile (3S,4R)-(-)-4-(4'-fluorophenyl)-3-hydroxymethyl)-piperidine (3S,4aS,8aS)-N-(tert-Butyl)-2-((2R,3R)-2-hydroxy-3-(3-hydroxy-2-methylbenzamido)-4-(phenylthio)butyl)decahydroisoquinoline-3-carboxamide (3S,4a,8aS)-2-((2R,3S)-3-Amino-2-hydroxy-4-phenylbutyl)-N-tert-butyldecahydroisoquinolin-3-carboxamide
|
|
